Page 5 of 12
REFERENCES
ACS Catalysis
through Structural Modification of the Parent Natural
Molecule, J. Med. Chem. 2017, 60, 4949-4962.
1
2
3
4
5
6
7
8
9
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
6
1
.
Efferth, T.; Li, P. C.; Konkimalla, V. S.; Kaina, B., From
Traditional Chinese Medicine to Rational Cancer Therapy,
Trends Mol. Med. 2007, 13, 353-361.
15. Polychronopoulos, P.; Magiatis, P.; Skaltsounis, A. L.;
Myrianthopoulos, V.; Mikros, E.; Tarricone, A.; Musacchio,
A.; Roe, S. M.; Pearl, L.; Leost, M.; Greengard, P.; Meijer,
L., Structural Basis for the Synthesis of Indirubins as
Potent and Selective Inhibitors of Glycogen Synthase
Kinase-3 and Cyclin-Dependent Kinases, J. Med. Chem.
2.
Gu, S.; Pei, J., Innovating Chinese Herbal Medicine: From
Traditional Health Practice to Scientific Drug Discovery,
Front. Pharmacol. 2017, 8, 381.
3
.
Hoessel, R.; Leclerc, S.; Endicott, J. A.; Nobel, M. E.; Lawrie,
A.; Tunnah, P.; Leost, M.; Damiens, E.; Marie, D.; Marko,
D.; Niederberger, E.; Tang, W.; Eisenbrand, G.; Meijer, L.,
2
004, 47, 935-946.
1
6. Wang, C. L.; Yan, J. X.; Du, M.; Burlison, J. A.; Li, C.; Sun,
Y. N.; Zhao, D. Q.; Liu, J. L., One Step Synthesis of
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
Indirubin, the Active Constituent of
a
Chinese
4
Indirubins by Reductive Coupling of Isatins with KBH ,
Tetrahedron 2017, 73, 2780-2785.
Antileukaemia Medicine, Inhibits Cyclin-Dependent
Kinases, Nat. Cell Biol. 1999, 1, 60-67.
17. Hu, S.; Huang, J.; Mei, L. H.; Yu, Q.; Yao, S. J.; Jin, Z. H.,
Altering the Regioselectivity of Cytochrome P450 BM-3 by
Saturation Mutagenesis for the Biosynthesis of Indirubin,
J. Mol. Catal. B-Enzym. 2010, 67, 29-35.
8. Ameria, S. P.; Jung, H. S.; Kim, H. S.; Han, S. S.; Kim, H. S.;
Lee, J. H., Characterization of a Flavin-Containing
Monooxygenase from Corynebacterium glutamicum and
Its Application to Production of Indigo and Indirubin,
Biotechnol. Lett. 2015, 37, 1637-1644.
9. Shi, S.; Ma, F.; Sun, T.; Li, A.; Zhou, J.; Qu, Y.,
Biotransformation of Indole to Indigo by the Whole Cells
of Phenol Hydroxylase Engineered Strain in Biphasic
Systems, Appl. Biochem. Biotechnol. 2013, 169, 1088-1097.
20. Rui, L.; Reardon, K. F.; Wood, T. K., Protein Engineering
of Toluene ortho-Monooxygenase of Burkholderia cepacia
G4 for Regiospecific Hydroxylation of Indole to Form
Various Indigoid Compounds, Appl. Microbiol. Biotechnol.
4
. Malumbres, M.; Barbacid, M., Cell Cycle, CDKs and
Cancer: A Changing Paradigm, Nat. Rev. Cancer 2009, 9,
1
53-166.
5
.
Leclerc, S.; Garnier, M.; Hoessel, R.; Marko, D.; Bibb, J. A.;
Snyder, G. L.; Greengard, P.; Biernat, J.; Wu, Y. Z.;
Mandelkow, E. M.; Eisenbrand, G.; Meijer, L., Indirubins
Inhibit Glycogen Synthase Kinase-3β and CDK5/P25, Two
1
Protein
Kinases
Involved
in
Abnormal
Tau
Phosphorylation in Alzheimer's Disease. A Property
Common to Most Cyclin-Dependent Kinase Inhibitors?, J.
Biol. Chem. 2001, 276, 251-260.
1
6
. Nam, S.; Buettner, R.; Turkson, J.; Kim, D.; Cheng, J. Q.;
Muehlbeyer, S.; Hippe, F.; Vatter, S.; Merz, K. H.;
Eisenbrand, G.; Jove, R., Indirubin Derivatives Inhibit Stat3
Signaling and Induce Apoptosis in Human Cancer Cells,
Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 5998-6003.
7
.
Kim, S. A.; Kim, Y. C.; Kim, S. W.; Lee, S. H.; Min, J. J.; Ahn,
S. G.; Yoon, J. H., Antitumor Activity of Novel Indirubin
Derivatives in Rat Tumor Model, Clin. Cancer. Res. 2007,
13, 253-259.
2
005, 66, 422-429.
2
1. Qu, Y. Y.; Xu, B. W.; Zhang, X. W.; Ma, Q.; Zhou, H.; Kong,
C. L.; Zhang, Z. J.; Zhou, J. T., Biotransformation of Indole
by Whole Cells of Recombinant Biphenyl Dioxygenase and
Biphenyl-2,3-Dihydrodiol-2,3-Dehydrogenase, Biochem.
Eng. J. 2013, 72, 54-60.
22. Zhang, X.; Qu, Y.; Ma, Q.; Kong, C.; Zhou, H.; Cao, X.;
Shen, W.; Shen, E.; Zhou, J., Production of Indirubin from
Tryptophan by Recombinant Escherichia coli Containing
Naphthalene Dioxygenase Genes from Comamonas sp.
Mq, Appl. Biochem. Biotechnol. 2014, 172, 3194-3206.
3. Han, G. H.; Gim, G. H.; Kim, W.; Seo, S. I.; Kim, S. W.,
Enhanced Indirubin Production in Recombinant
Escherichia coli Harboring
Monooxygenase Gene by Cysteine Supplementation, J.
Biotechnol. 2012, 164, 179-187.
4. Kim, J.; Lee, P. G.; Jung, E. O.; Kim, B. G., In Vitro
Characterization of CYP102G4 from Streptomyces cattleya:
8. Blazevic, T.; Heiss, E. H.; Atanasov, A. G.; Breuss, J. M.;
Dirsch, V. M.; Uhrin, P., Indirubin and Indirubin
Derivatives for Counteracting Proliferative Diseases, Evid.
Based Complement. Alternat. Med. 2015, 2015, 654098.
9
. Park, W. S.; Park, G. J.; Han, S.; Ban, S.; Park, M. Y.; Kim,
S. H.; Kim, S. M.; Kim, Y. C.; Kim, H. S.; Shin, Y. G.; Yim,
D. S., Human Microdosing and Mice Xenograft Data of
AGM-130 Applied to Estimate Efficacious Doses in
Patients, Cancer Chemother. Pharmacol. 2017, 80, 363-369.
2
1
1
1
0. Lin, Y. K.; See, L. C.; Huang, Y. H.; Chi, C. C.; Hui, R. C.,
Comparison of Indirubin Concentrations in Indigo
a
Flavin-Containing
Naturalis Ointment for Psoriasis Treatment:
A
Randomized, Double-Blind, Dosage-Controlled Trial, Br. J.
Dermatol. 2018, 178, 124-131.
2
1. Sato, N.; Meijer, L.; Skaltsounis, L.; Greengard, P.;
Brivanlou, A. H., Maintenance of Pluripotency in Human
and Mouse Embryonic Stem Cells through Activation of
Wnt Signaling by a Pharmacological GSK-3-Specific
Inhibitor, Nat. Med. 2003, 10, 55.
2. Ying, Q. L.; Wray, J.; Nichols, J.; Batlle-Morera, L.; Doble,
B.; Woodgett, J.; Cohen, P.; Smith, A., The Ground State of
Embryonic Stem Cell Self-Renewal, Nature 2008, 453, 519-
A
Self-Sufficient P450 Naturally Producing Indigo,
Biochim. Biophys. Acta Proteins Proteom. 2018, 1866, 60-
67.
2
5. Sánchez-Viesca, F.; Gómez, R., On the Baeyer-Emmerling
Synthesis of Indigo, World Journal of Organic Chemistry
2
018, 6, 6-12.
2
6. Russell, G. A.; Kaupp, G., Reactions of Resonance
Stabilized Carbanions. XXXI. Oxidation of Carbanions. 4.
Oxidation of Indoxyl to Indigo in Basic Solution, J. Am.
Chem. Soc. 1969, 91, 3851-3859.
7. Wongsaroj, L.; Sallabhan, R.; Dubbs, J. M.; Mongkolsuk, S.;
Loprasert, S., Cloning of Toluene 4-Monooxygenase Genes
and Application of Two-Phase System to the Production of
the Anticancer Agent, Indirubin, Mol. Biotechnol. 2015, 57,
720-726.
5
23.
13. Du, J.; Yang, D.; Luo, Z. W.; Lee, S. Y., Metabolic
Engineering of Escherichia coli for the Production of
Indirubin from Glucose, J. Biotechnol. 2018, 267, 19-28.
2
1
4. Cheng, X.; Merz, K. H.; Vatter, S.; Zeller, J.; Muehlbeyer, S.;
Thommet, A.; Christ, J.; Wolfl, S.; Eisenbrand, G.,
Identification of a Water-Soluble Indirubin Derivative as
Potent Inhibitor of Insulin-Like Growth Factor 1 Receptor
2
8. Li, Q. S.; Schwaneberg, U.; Fischer, P.; Schmid, R. D.,
Directed Evolution of the Fatty-Acid Hydroxylase P450
ACS Paragon Plus Environment